DYNAMICS OF MECHANICAL DYSSYNCHRONY IN PATIENTS WITH SUPERRESPONSE TO CARDIAC RESYNCHRONISATION THERAPY WITH A LONG-TERM FOLLOW-UP

Author:

Shirokov N. E.,Kuznetsov V. A.,Soldatova A. M.,Diachkov S. M.,Krinochkin D. V.

Abstract

Aim. The aim is to assess clinical features of organism and morpho-functional properties of heart and to study the dynamics of mechanical dyssynchrony in patients with congestive heart failure and superresponse to cardiac resynchronization therapy.Material and Methods. 72 patients were examined (mean age 54.3±8.9 years) at baseline and during follow-up visits: 10.5±3.7 months, 52.0±21.4 months. Patients were divided into groups: I group (n=31) with decrease of left ventricle endsystolic volume ≥30% (superresponders) and II group (n=41) — decrease of left ventricle endsystolic volume <30% (nonsuperresponders).Results. At baseline there were differences in the presence of myocardial infarction (22.5% in I group vs 46.3% in II group; p=0.038), the groups were comparable in severity of electrical and mechanical dyssynchrony. Left ventricle pre-ejection period in I group was statistically significantly decreased at both control visits, in group II there was no significant change. Right ventricular pre-ejection period significantly increased only in I group at the second control visit compared to baseline values. The mechanical interventricular delay significantly decreased in I group at both control visits compared to baseline values, in II group only at first control visit. The Intraventricular dyssynchrony assessed by tissue doppler imaging significantly decreased in both groups compared to baseline values. The survival rate in I group was 87.1%, in group II was 65.9% (Log-Rank test p=0.038).Discussion. Based on the results of the subanalysis of the Echo-CRT study, it was shown that a decrease in mechanical dyssynchrony in patients with cardiac resynchronization therapy is associated with a lower incidence of hospitalization due to heart failure or death. Persistent or worsening dyssynchrony according to echocardiography may be a marker of a severity of the disease in patients with congestive heart failure and has a prognostic value. It is important to note that in our study the described facts confirm the preservation of cardiac resynchronization therapy effect with long follow-up in superresponders and limited cardiac resynchronization therapy effect with short follow-up in nonsuperresponders.Conclusion. Superresponse is associated with a decrease of mechanical dyssynchrony with a long-term follow-up also with a higher survival rate.

Publisher

Cardiology Research Institute

Reference25 articles.

1. Brignole M., Auricchio A., Baron-Esquivias G., Bordachar P., Boriani G., Breithardt O. A., Cleland J., Deharo J. C., Delgado V., Elliott P. M., Gorenek B., Israel C. W., Leclercq C., Linde C., Mont L., Padeletti L., Sutton R., Vardas P. E. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 2013 The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur. Heart J. 2013; 34(29): 2281–2329. DOI: 10.1093/eurheartj/eht150.

2. Ponikowski P., Voors A. A., Anker S. D., Bueno H., Cleland J. G., Coats A. J., Falk V., González-Juanatey J. R., Harjola V. P., Jankowska E. A., Jessup M., Linde C., Nihoyannopoulos P., Parissis J. T., Pieske B., Riley J. P., Rosano G. M., Ruilope L. M., Ruschitzka F., Rutten F. H., van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016; 37: 2129–2200. DOI: 10.1093/eurheartj/ehw128.

3. Kuznetsov V. A. cardiac resynchronisation therapy: selected questions. Moscow: Abys; 2007: 128 (In Russ).

4. Galli E., Leclercq C., Donal E. Mechanical dyssynchrony in heart failure: Still a valid concept for optimizing treatment? Arch. Cardiovasc. Dis. 2017; 110(1): 60–68. DOI: 10.1016/j.acvd.2016.12.002.

5. Risum N. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy. Dan. Med. J. 2014; 61(12): B4981.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3